An anti-EGFR antibody
Cetuximab
A targeted antibody for certain bowel and head and neck cancers, given by drip by oncology teams.
What is Cetuximab?
Cetuximab is a targeted cancer medicine (a monoclonal antibody) used for certain bowel cancers and some head and neck cancers. It is given by a specialist oncology team as a drip into a vein, often with chemotherapy or radiotherapy. It works only when the bowel cancer has normal (RAS wild-type) genes, so the cancer is tested first. Its most recognisable side effect is an acne-like skin rash, which is often a sign the medicine is working, and it can lower magnesium levels in the blood. Infusion reactions can happen, so you are watched closely.
Education and reference only. This is a plain-language guide to Cetuximab — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Cetuximab is a monoclonal antibody, a laboratory-made protein that targets EGFR, a growth protein on the surface of some cancer cells. It is used for certain bowel cancers that have normal (RAS wild-type) genes and for some head and neck cancers, often alongside chemotherapy or radiotherapy. It is not a tablet; it is given by oncology specialists as a drip into a vein. The brand name is Erbitux.
How it works
EGFR is a protein that, when switched on, tells cells to grow and divide; some cancers rely heavily on it. Cetuximab attaches to EGFR and blocks this growth signal, which can slow or shrink the cancer, particularly when combined with chemotherapy or radiotherapy. It only works if the cancer's RAS genes are normal (wild-type), because a faulty RAS gene keeps the growth signal switched on inside the cell regardless of EGFR, so the cancer is tested first. Blocking EGFR in the skin and gut explains the typical acne-like rash and the drop in magnesium.
Company & origin
Originated / developed by: Merck.
A targeted cancer antibody used in the UK by oncology teams for certain bowel and head and neck cancers.
Practical use
How to take Cetuximab
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- It is given by your oncology team as a drip into a vein, often alongside chemotherapy or radiotherapy; it is never taken as a tablet.
- You will usually be given supportive medicines before the drip to lower the chance of an infusion reaction.
- Look after your skin with the moisturisers and advice your team gives, and protect your skin from the sun, as a rash is common.
- Attend blood tests to check your magnesium and other levels, which may need topping up.
- Tell your team about a severe or infected rash, or muscle cramps or twitching that can signal low magnesium.
Weighing it up
Advantages & disadvantages of Cetuximab
Advantages
- Specifically targets EGFR and can slow or shrink suitable bowel and head and neck cancers.
- Works well alongside chemotherapy or radiotherapy as part of a planned treatment.
- The skin rash, although a nuisance, is often a sign that the medicine is working.
Disadvantages
- Commonly causes an acne-like skin rash that can be uncomfortable and need skin care.
- Lowers magnesium levels, which needs regular blood tests and sometimes replacement.
- Only helps bowel cancers with normal (RAS wild-type) genes, and infusion reactions can occur.
Practical use
Good to know
Cetuximab is only used when bowel cancer testing shows normal (RAS wild-type) genes, as it will not help cancers with a faulty RAS gene. The most noticeable effect is an acne-like rash on the face and upper body, which can be uncomfortable but is often a sign the medicine is working; your team can advise on creams and care for it, and on sun protection. It commonly lowers magnesium in the blood, so this is checked and topped up if needed. Infusion reactions can happen, sometimes with the first dose, so you are watched closely and given supportive medicines. Tell your team about a severe rash, any signs of infected skin, or symptoms of low magnesium such as muscle cramps or twitching.
Who should not take it / use with caution
- It is not used for bowel cancers that have a faulty (mutated) RAS gene, as it will not work.
- Anyone who has had a serious allergic reaction to cetuximab should not receive it again.
- It is avoided in pregnancy because it can harm the developing baby, so effective contraception is advised.
Monitoring
- Regular blood tests to check magnesium and other salts, with replacement if they fall.
- Watching the skin for rash and any signs of infection, with advice on skin care.
- Infusion-reaction checks during the drip and review of how the cancer is responding.
Side effects
- An acne-like skin rash, often on the face and upper body, which can be a sign it is working.
- Low magnesium in the blood, which is monitored and replaced if needed.
- Infusion reactions, tiredness, sore mouth, diarrhoea and dry or cracked skin.
Key interactions
- Given as a planned combination with chemotherapy or radiotherapy rather than an accidental interaction.
- Other medicines or conditions that lower magnesium may add to the effect, so levels are watched.
- Tell your team about all your medicines so monitoring and skin care can be tailored.
Available as: Given by oncology teams as a drip into a vein.
Answers
Cetuximab: frequently asked questions
Why do I have an acne-like rash on cetuximab?
Cetuximab blocks EGFR, which is also active in the skin, so an acne-like rash is common; it can be a sign the medicine is working, and your team can advise on skin care.
Why was my cancer tested for RAS genes first?
Cetuximab only helps bowel cancers with normal (RAS wild-type) genes; a faulty RAS gene keeps the growth signal switched on regardless, so it would not work.
Why is my magnesium being checked?
Cetuximab can lower magnesium in the blood, so it is checked regularly and topped up if needed; tell your team about muscle cramps or twitching.
Is cetuximab chemotherapy?
No. It is a targeted antibody against the EGFR protein, often given together with chemotherapy or radiotherapy, which work in different ways.
What should I do about the rash?
Use the moisturisers and advice your team provides and protect your skin from the sun; tell your team if the rash is severe or looks infected.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.